Any value of podocyte b7-1 as a biomarker in human MCD and FSGS?

American Journal of Physiology - Renal Physiology

Volumn 310, Issue 5, 2016, Pages F335-F341

  Novelli, Rubina ^a   Gagliardini, Elena ^a   Ruggiero, Barbara ^a   Benigni, Ariela ^a   Remuzzi, Giuseppe ^a,b,c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Hospital Papa Giovanni XXIII   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

B7 1; Focal segmental glomerulosclerosis; Minimal change disease; Podocytes

Indexed keywords

ABATACEPT; ANTIBODY; B7 ANTIGEN; BELATACEPT; BIOLOGICAL MARKER; CREATININE; DOXORUBICIN; LIPOPOLYSACCHARIDE; STEROID;

ADRIAMYCIN-INDUCED NEPHROPATHY; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; MALE; MIDDLE AGED; MINIMAL CHANGE GLOMERULONEPHRITIS; MOUSE; NONHUMAN; PODOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; SCHOOL CHILD; STEROID THERAPY; UPREGULATION; YOUNG ADULT; ANIMAL; BAGG ALBINO MOUSE; CASE CONTROL STUDY; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; METABOLISM; NEPHROSIS, LIPOID; PREDICTIVE VALUE;

ADULT; AGED; ANIMALS; ANTIGENS, CD80; BIOMARKERS; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; DOXORUBICIN; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE, INBRED BALB C; MIDDLE AGED; NEPHROSIS, LIPOID; PODOCYTES; PREDICTIVE VALUE OF TESTS; YOUNG ADULT;

EID: 84979098154     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00510.2015     Document Type: Article

References (25)

1. Alachkar N, Carter-Monroe N, Reiser J. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 370: 1263-1264, 2014.
2. Benigni A, Gagliardini E, Remuzzi G. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 370: 1261-1263, 2014.
3. Bhatia S, Edidin M, Almo SC, Nathenson SG. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. Immunol Lett 104: 70-75, 2006.
4. Cara-Fuentes G, Wasserfall CH, Wang H, Johnson RJ, Garin EH. Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis? Pediatr Nephrol 29: 2333-2340, 2014.
5. D’Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med 365: 2398-2411, 2011.
6. Dorfman DM, Schultze JL, Shahsafaei A, Michalak S, Gribben JG, Freeman GJ, Pinkus GS, Nadler LM. In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation. Blood 90: 4297-4306, 1997.
7. Fiorina P, Vergani A, Bassi R, Niewczas MA, Altintas MM, Pezzolesi MG, D’Addio F, Chin M, Tezza S, Ben Nasr M, Mattinzoli D, Ikehata M, Corradi D, Schumacher V, Buvall L, Yu CC, Chang JM, La Rosa S, Finzi G, Solini A, Vincenti F, Rastaldi MP, Reiser J, Krolewski AS, Mundel PH, Sayegh MH. Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol 25: 1415-1429, 2014.
8. Fogo AB. Minimal change disease and focal segmental glomerulosclerosis. Nephrol Dial Transplant 16, Suppl 6: 74-76, 2001.
9. Gagliardini E, Novelli R, Corna D, Zoja C, Ruggiero B, Benigni A, Remuzzi G. B7-1 Is not induced in podocytes of human and experimental diabetic nephropathy. J Am Soc Nephrol. In press.
10. Garin EH, Diaz LN, Mu W, Wasserfall C, Araya C, Segal M, Johnson RJ. Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 20: 260-266, 2009.
11. Garin EH, Reiser J, Cara-Fuentes G, Wei C, Matar D, Wang H, Alachkar N, Johnson RJ. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis. Pediatr Nephrol 30: 469-477, 2015.
12. Glassock RJ. Therapy of relapsing minimal-change disease in adults: a new approach? Kidney Int 83: 343-345, 2013.
13. Grellier J, Del Bello A, Milongo D, Guilbeau-Frugier C, Rostaing L, Kamar N. Belatacept in recurrent focal segmental glomerulosclerosis after kidney transplantation. Transpl Int 28: 1109-1110, 2015.
14. Grimbert P, Audard V, Remy P, Lang P, Sahali D. Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol Dial Transplant 18: 245-248, 2003.
15. Ichikawa I, Fogo A. Focal segmental glomerulosclerosis. Pediatr Nephrol 10: 374-391, 1996.
16. Kyrieleis HA, Lowik MM, Pronk I, Cruysberg HR, Kremer JA, Oyen WJ, van den Heuvel BL, Wetzels JF, Levtchenko EN. Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children. Clin J Am Soc Nephrol 4: 1593-1600, 2009.
17. Larsen CP, Messias NC, Walker PD. B7-1 immunostaining in proteinuric kidney disease. Am J Kidney Dis 64: 1001-1003, 2014.
18. Laszik Z, Dobi S, Vincenti F. B7-1/CD80 is not a reliable immunophenotypical marker of focal segmental glomerulosclerosis, membranous nephropathy, and diabetic nephropathy (Abstract). J Am Soc Nephrol 25: 18A, 2014.
19. Lee VW, Harris DC. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology (Carlton) 16: 30-38, 2011.
20. Mundel P, Greka A. Developing therapeutic “arrows” with the precision of William Tell: the time has come for targeted therapies in kidney disease. Curr Opin Nephrol Hypertens 24: 388-392, 2015.
21. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T, Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 167: 5067-5076, 2001.
22. Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L, Rastaldi MP, Calvaresi N, Watanabe H, Schwarz K, Faul C, Kretzler M, Davidson A, Sugimoto H, Kalluri R, Sharpe AH, Kreidberg JA, Mundel P. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 113: 1390-1397, 2004.
23. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8: 769-776, 1997.
24. Wu Q, Jinde K, Endoh M, Sakai H. Costimulatory molecules CD80 and CD86 in human crescentic glomerulonephritis. Am J Kidney Dis 41: 950-961, 2003.
25. Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, Chen L, Ciancio G, Faridi MH, Behr D, Campbell KN, Chang JM, Chen HC, Oh J, Faul C, Arnaout MA, Fiorina P, Gupta V, Greka A, Burke GW, 3rd, Mundel P. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 369: 2416-2423, 2013.